Since the identification of the Orai1 Ca2+ channel as the archetype of SOCE (35), Orai1 is now considered a plausible target in several pathological processes, including left heart failure, asthma, pancreatitis, muscular myopathy, inflammation, thrombocytopenia, and PAH. The gene discussed is ORAI1; the disease is Thrombocytopenia.